The Nature Medicine fatty liver trial made the same point: 8 mg achieved 81 percent liver fat reduction, 12 mg achieved 82 percent
For individuals experiencing more dramatic volume loss or excess skin, surgical rejuvenation provides the most comprehensive and long-lasting correction
By promoting feelings of fullness and slowing gastric emptying, they reduce calorie consumption, making it simpler for people to sustain a calorie deficit and lose weight in a long-term way
Currently available GLP-1 receptor agonists in the UK include: Exenatide (short-acting and extended-release formulations) - licensed for type 2 diabetes Liraglutide (once-daily injection) - licensed for type 2 diabetes (Victoza) and separately for weight management (Saxenda 3mg) Dulaglutide (once-weekly injection) - licensed for type 2 diabetes, including cardiovascular risk reduction in those with established cardiovascular disease or multiple risk factors Semaglutide (once-weekly injection and oral formulation) - licensed for type 2 diabetes (Ozempic, Rybelsus) and separately for weight management (Wegovy 2.4mg) A related but distinct medication is tirzepatide (once-weekly injection), which is a dual GIP/GLP-1 receptor agonist licensed for type 2 diabetes management
High-Fiber Foods High-fiber foods like non-starchy vegetables and berry fruits feed beneficial gut bacteria and produce short-chain fatty acids that can help prompt natural GLP-1 and satiety, with research showing fermentable fiber increases GLP-1 release in humans and animals
Without that downstream switch, mobilized fat can simply circulate and end up re-stored
